Mitsubishi Tanabe Pharma Corporation

Japanese pharmaceutical company headquartered in Osaka, formed in 2007 from the merger of Mitsubishi Pharma with Tanabe Seiyaku, whose origins go back to 1678, and now part of the Mitsubishi Chemical Group. Develops, manufactures and markets prescription medicines with a focus on central nervous system and immuno-inflammation, diabetes and kidney disease and vaccines, including edaravone for amyotrophic lateral sclerosis, and runs research and manufacturing sites in Japan and abroad with subsidiaries in the United States and Europe.